Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

This study is testing a procedure called HIPEC (heated chemotherapy delivered directly into the belly cavity during a minimally invasive surgery) in patients with advanced stomach cancer that has spread to the lining of the abdomen (called peritoneal metastases). The goal is to see if this approach can help control the cancer. **You may be eligible if...** - You have been diagnosed with stomach cancer that has spread to the lining of the abdominal cavity, confirmed by biopsy - You have already completed 2 to 4 months of chemotherapy - You are 18 years old or older - You are reasonably active (ECOG 0–2) - Your blood counts and organ function are adequate **You may NOT be eligible if...** - Your cancer has spread beyond the abdominal lining to other distant organs - You have uncontrolled infections (HIV, hepatitis B or C) - You are younger than 18 (children are excluded from this study) Talk to your doctor to see if this trial is right for you.